European Journal of Clinical Microbiology

, Volume 4, Issue 1, pp 72–73 | Cite as

In vitro activity of five quinoline derivatives against nosocomial isolates ofStaphylococcus andPseudomonas species

  • F. D. Daschner
  • H. -M. Just


Internal Medicine Quinoline Vitro Activity Quinoline Derivative Nosocomial Isolate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Shrire, L., Saunders, J., Traynor, R., Koornhof, H. J.; A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. European Journal of Clinical Microbiology 1984, 3: 328–332.PubMedGoogle Scholar
  2. 2.
    Hoogkamp-Korstanje, J. A. A.: Comparative in vitro activity of five quinolone derivatives and five other antimicrobial agents used in oral therapy. European Journal of Clinical Microbiology 1984, 3: 333–338.PubMedGoogle Scholar
  3. 3.
    Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 09867, a new quinoline derivative, compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.PubMedGoogle Scholar
  4. 4.
    Bauernfeind, A., Petermüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.PubMedGoogle Scholar

Copyright information

© Vieweg Publishing 1985

Authors and Affiliations

  • F. D. Daschner
    • 1
  • H. -M. Just
    • 1
  1. 1.Department of Hospital EpidemiologyUniversity HospitalFreiburgFRG

Personalised recommendations